What's new

Human medicines European public assessment report (EPAR): Tysabri, natalizumab, Date of authorisation: 27/06/2006, Revision: 48, Status: Authorised

Human medicines European public assessment report (EPAR): Tysabri, natalizumab, Date of authorisation: 27/06/2006, Revision: 48, Status: Authorised

Jun 19, 2025 - 13:45
 0
Human medicines European public assessment report (EPAR): Tysabri, natalizumab, Date of authorisation: 27/06/2006, Revision: 48, Status: Authorised
Human medicines European public assessment report (EPAR): Tysabri, natalizumab, Date of authorisation: 27/06/2006, Revision: 48, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Avtozma, tocilizumab, ...

Next Article

Human medicines European public assessment report (EPAR): Pazenir, paclitaxel, D...

Related Posts

EMEA-003546-PIP01-23

EMEA-003546-PIP01-23

Jun 11, 2025  0

Human medicines European public assessment report (EPAR): Vegzelma, bevacizumab, Date of authorisation: 17/08/2022, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR...

May 23, 2025  0

Human medicines European public assessment report (EPAR): Blincyto, blinatumomab, Date of authorisation: 23/11/2015, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR...

May 13, 2025  0